BOLD — BOUNDLESS BIO INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About BOUNDLESS BIO INC (BOLD)
BOUNDLESS BIO INC (BOLD) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $2M. Across recent filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BOLD
How many top investors track BOLD
Only 2 tracked investors report this position.
BOLD Ownership Composition
How BOUNDLESS BIO INC is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting BOLD
- Ken GriffinMar 31, 2026Citadel AdvisorsShares1.3MValue$1.5M% Portfolio0.00%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares99.9KValue$109.9K% Portfolio0.00%
Recent activity
- $162.5KFeb 17, 2026
- $109.9KMay 15, 2026
- New$1.5MMay 15, 2026
- New$1.1MNov 14, 2025
Frequently asked questions
- How many institutional investors hold BOLD?
- 2 tracked institutional investors disclosed a position in BOLD (BOUNDLESS BIO INC) in their most recent 13F filing.
- Who is the largest institutional holder of BOLD?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in BOLD, valued at $2M.
- Did institutional ownership of BOLD increase or decrease?
- Across recent 13F filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 fully exited BOLD.
- Where does this BOLD ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.